Table 2 Pertinent characteristics of included and excluded patients
Variable | Included (n = 2395) | Excluded (n = 817) | p value* |
|---|---|---|---|
Age (years; mean ± SD) | 58.1 (7.8) | 57.9 (11.7) | 0.71 |
Female gender (%, n) | 60.8 (1457/2395) | 57.8 (472/817) | 0.13 |
BMI (kg/m2; mean ± SD) | 29.4 (5.0) | 29.3 (4.7) | 0.38 |
Obesity (%, n) | 40.8 (976/2395) | 39.4 (318/808) | 0.52 |
Central obesity (%, n) | 60.7 (1452/2393) | 60.6 (477/787) | 0.81 |
Smoking | |||
 Current (%, n) | 16.0 (382/2395) | 19.7 (161/817) | 0.03 |
 Past (%, n) | 26.2 (628/2395) | 24.8 (203/817) | 0.27 |
Hypertension (%, n) | 49.1 (1175/2392) | 52.1 (420/806) | 0.19 |
Blood pressure (mmHg) | |||
 Systolic (mean ± SD) | 138.6 (17.9) | 139.6 (18.3) | 0.20 |
 Diastolic (mean ± SD) | 82.8 (10.3) | 84.5 (10.7) | 0.0002 |
Blood lipids (mmol/l) | |||
 Total cholesterol (mean ± SD) | 5.63 (1.19) | 5.60 (1.18) | 0.63 |
 HDL cholesterol (mean ± SD) | 1.31 (0.32) | 1.30 (0.34) | 0.29 |
 LDL cholesterol (mean ± SD) | 3.58 (1.03) | 3.54 (1.01) | 0.52 |
 Triglycerides (mean ± SD) | 1.66 (1.02) | 1.73 (1.19) | 0.56 |
Plasma glucose (mmol/l) | |||
 Fasting (mean ± SD) | 6.24 (0.91) | 6.40 (0.83)** | 0.02 |
 2 h postload (mean ± SD) | 7.34 (2.28) | 7.62 (2.26)*** | 0.13 |
 HbA1c (%)(mean ± SD) | 5.67 (0.50) | 5.75 (0.67)**** | 0.0003 |
Pharmacological treatment | |||
 ASA/antiplatelets (%, n) | 27.8 (665/2391) | 25.0 (204/815) | 0.14 |
 Lipid lowering (%, n) | 31.0 (741/2391) | 39.1 (318/814) | < 0.0001 |
 Beta-blockers (%, n) | 30.5 (730/2392) | 31.5 (256/813) | 0.53 |
 ACE-inhibitors (%, n) | 48.2 (1153/2392) | 49.0 (399/814) | 0.71 |
 AT-II receptor blockers (%, n) | 18.9 (452/2392) | 19.8 (161/813) | 0.56 |
 Calcium channel blockers (%, n) | 22.4 (535/2392) | 26.3 (214/814) | 0.03 |
 Diuretics (%, n) | 29.4 (703/2391) | 31.5 (257/815) | 0.21 |
 Low educational level (%, n) | 10.5 (250/2382) | 14.7 (120/816) | 0.002 |
 Low or moderate physical activity (%, n) | 55.4 (1295/2337) | 61.5 (487/792) | 0.001 |